Christopher Beck
Director de Operaciones en CONTEXT THERAPEUTICS INC. .
Perfil
Christopher Beck is a professional with experience in various pharmaceutical companies.
He is currently working as Senior Vice President-Operations at Context Therapeutics, Inc. Prior to this, he worked as Vice President-Program Management at Galera Therapeutics, Aevi Genomic Medicine, and Formular Pharmaceuticals.
He completed his undergraduate degree at Drexel University and earned an MBA from The Pennsylvania State University.
Cargos activos de Christopher Beck
| Empresas | Cargo | Inicio |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Director de Operaciones | 05/01/2022 |
Antiguos cargos conocidos de Christopher Beck.
| Empresas | Cargo | Fin |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
| Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de Christopher Beck.
| Drexel University | Undergraduate Degree |
| The Pennsylvania State University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| CONTEXT THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Formular Pharmaceuticals, Inc. |
- Bolsa de valores
- Insiders
- Christopher Beck
